Wyoming governor signs ban on abortions after about 6 weeks but cites misgivings
Wyoming Gov. Mark Gordon on Monday signed ban on abortions after embryotic cardiac activity can be detected, generally at about… Wyoming Gov. Mark…
THE HELITRA EDIT
Tag: cites
Piper Sandler ups Intra-Cellular to obese, cites Caplyta potential
Piper Sandler ups Intra-Cellular to obese, cites Caplyta potential Source: Seekingalpha
Stifel starts ORIC at purchase, cites prostate cancer drug candidate
Stifel starts ORIC at purchase, cites prostate cancer drug candidate Source: Seekingalpha
Piper Sandler ups Intra-Cellular to chubby, cites Caplyta potential
Piper Sandler ups Intra-Cellular to chubby, cites Caplyta potential Source: Seekingalpha
Stifel starts ORIC at purchase, cites prostate cancer drug candidate
Stifel starts ORIC at purchase, cites prostate cancer drug candidate Source: Seekingalpha
Piper Sandler ups Intra-Cellular to obese, cites Caplyta potential
Piper Sandler ups Intra-Cellular to obese, cites Caplyta potential Source: Seekingalpha
Stifel starts ORIC at purchase, cites prostate cancer drug candidate
Stifel starts ORIC at purchase, cites prostate cancer drug candidate Source: Seekingalpha
Roth starts CG Oncology at purchase, cites anticipated FDA filing
Roth starts CG Oncology at purchase, cites anticipated FDA filing Source: Seekingalpha
BofA starts Biohaven at purchase, cites “fast-follower” approach (NYSE:BHVN)
peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase ranking, citing its drug improvement applications for temper and autoimmune problems. The funding…
BofA starts Biohaven at purchase, cites “fast-follower” approach (NYSE:BHVN)
peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase ranking, citing its drug improvement applications for temper and autoimmune issues. The funding…
BofA starts Biohaven at purchase, cites “fast-follower” approach (NYSE:BHVN)
peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase score, citing its drug improvement packages for temper and autoimmune problems. The funding…